| ID | Name | CAS | Data |
MW (g/mol) |
| 12-567-9 |
trans-1-Methyl-2-tert-butyl-3-(tert-butylimino)diaziridine
|
23044-57-7 |
3 | 183.29 |
| 12-569-7 |
Silane, dimethyl(dimethyl(2-bromo-4fluorophenoxy)silyloxy)(2-bromo-4-fluorophenoxy)-
|
|
3 | 512.29 |
| 12-883-8 |
L-Proline, N-trifluoroacetyl-, 2,2,3,3,3-pentafluoropropyl ester
|
|
3 | 343.17 |
| 12-903-5 |
N-(4-Methoxy-1,3-benzothiazol-2-yl)-2,2,3,3,4,4,4-heptafluorobutanamide
|
|
3 | 376.25 |
| 13-043-9 |
5'-S-Methyl-5'-thioadenosine, N,O,O'-tris(trifluoroacetyl)-
|
|
3 | 585.36 |
| 13-084-4 |
[1R-(1«alpha»,7a«beta»)]-[1-((Z)-2-Methyl-1-oxobut-2-enyloxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl ester of (Z)-2-hydroxymethylbut-2-enoic acid
|
87340-27-0 |
3 | 335.39 |
| 13-180-7 |
5«alpha»-Androstane-3«beta»,17«beta»-diol,bis-TMS
|
|
3 | 436.82 |
| 13-232-9 |
tert-Butyldimethylsilyl 2-[(3,5,6-trichloro-2-pyridyl)oxy]acetate
|
|
3 | 370.73 |
| 13-326-5 |
allo-Cholanic acid, 3«beta»,7«alpha»,12«beta»-trihydroxy, Me-TMS
|
|
3 | 639.14 |
| 13-391-3 |
2H-Furo[2,3-h]-1-benzopyran-2-one, 8,9-dihydro-8-(1-hydroxy-1-methylethyl)-, (S)-
|
3804-70-4 |
3 | 246.26 |
| 13-413-8 |
3,5-Dihydro-4-(methylimino)-4H-pyrazole, 3,3,5,5-tetramethyl-
|
72443-11-9 |
3 | 153.22 |
| 13-482-2 |
3.alpha.,5.beta.-dihydroxy-5.beta.-cholan-24-oic acid, TMS
|
|
3 | 609.13 |
| 13-534-4 |
N-(5,6-Dichloro-1,3-benzothiazol-2-yl)-2,2,3,3,4,4,4-heptafluorobutanamide
|
|
3 | 415.12 |
| 13-641-5 |
Androstan-17-one, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3«alpha»,5«beta»)-
|
65598-73-4 |
3 | 404.70 |
| 13-690-1 |
5-Cholenoic acid, 3-«beta»,12-«alpha»-dihydroxy, methyl ester, TMS
|
|
3 | 548.94 |
| 13-713-5 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl neopentyl ester
|
|
3 | 335.44 |
| 13-761-2 |
3«alpha»-Hydroxy-5«alpha»-pregnan-20-one-O-methyloxime, triimethylsilyl
|
|
3 | 419.72 |
| 13-818-9 |
5«beta»-cholestane, 3«alpha»,7«beta»,12«alpha»-trihydroxy, TMS
|
|
3 | 637.21 |
| 13-921-4 |
1,3-Hexadiene, adduct with 4-methyl-1,2,4-triazolin-3,5-dione
|
|
3 | 195.22 |
| 14-128-4 |
Pyridine, 1,1'-(1,4-phenylenedicarbonyl)bis[1,2,3,4-tetrahydro-
|
|
3 | 296.37 |
| 14-269-8 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (3-O)-TBDMSi
|
|
3 | 434.77 |
| 14-306-6 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (3-O)-TBDMSi, (20-O)-TMSi
|
|
3 | 506.95 |
| 14-839-5 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5,6-trimethyl-7,7-tetramethylene
|
|
3 | 236.31 |
| 14-864-7 |
Silane, [(3«beta»)-cholesta-5,7-dien-3-yloxy]trimethyl-
|
2625-44-7 |
3 | 456.82 |
| 14-907-9 |
2-Amino-4,6-dihydroxypyrimidine, N,O,O'-tris(heptafluorobutyryl)-
|
|
3 | 715.17 |
| 14-988-0 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, ethyl ester
|
|
3 | 397.31 |
| 15-033-8 |
Europium, tris(2,2,6,6-tetramethyl-3,5-heptanedionato)-
|
15522-71-1 |
3 | 701.77 |
| 15-320-9 |
1H-Pyrrolizine-1-methanol, hexahydro-7-hydroxy-, [1S-(1«alpha»,7«alpha»,7a«beta»)]-
|
520-62-7 |
3 | 157.21 |
| 15-373-1 |
1H-Naphtho[2,1-b]pyran-1-one, 3-phenyl-
|
6051-87-2 |
3 | 272.30 |
| 15-609-9 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, hexyl ester
|
|
3 | 401.42 |
| 15-689-1 |
4,12-Dipropyl-4,7,7,9,9,12-hexamethyl-8-oxa-4,7,9,12-tetrasilapentadecane
|
|
3 | 447.02 |
| 15-696-3 |
3«alpha»,16«alpha»-dihydroxy-5«alpha»-androstan-17-one, TMS
|
|
3 | 450.80 |
| 15-806-0 |
5-Methyl-2H-pyrazole-3-carboxylic acid, 1-methyl-2-isopropenyl hydrazide
|
|
3 | 194.23 |
| 16-093-1 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, propyl ester
|
|
3 | 411.34 |
| 16-211-9 |
1-(4-Methylphenyl)butan-1-one, O-(tert-butyldimethylsilyl)oxime
|
|
3 | 291.50 |
| 16-363-1 |
1,1,3,3-Tetramethyl-1,3-(di-3-chlorpropyl)-disiloxane
|
|
3 | 287.37 |
| 16-407-2 |
Benzofuran-2,3-dione, 2-[O-(2-acetoxyethyl)oxime], 3-(O-methyloxime), isomer 2
|
|
3 | 278.26 |
| 16-439-7 |
allo-Cholanic acid, 3«alpha»,7«alpha»-dihydroxy, Me-DMES
|
|
3 | 579.01 |
| 16-587-3 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 5,6-trimethyleno, 6-methyl
|
|
3 | 200.24 |
| 16-756-5 |
5«beta»-Homocholane-3«alpha»,7«alpha»,25-triol, TMS
|
|
3 | 609.16 |
| 16-837-5 |
2,8,9-Trioxa-5-aza-1-silabicyclo[3.3.3]undecane, 1-phenyl-
|
2097-19-0 |
3 | 251.35 |
| 17-014-7 |
epi-5«beta»-Stigmastanol (24«beta»-ethyl-5«beta»-cholestan-3«alpha»-ol), TMS
|
|
3 | 488.90 |
| 17-118-2 |
24-Nor-3«alpha»,7«beta»-dihydroxy-5«beta»-cholanoic acid, MeTMS
|
|
3 | 536.93 |
| 17-121-8 |
6,7,8,9,10,11-Hexahydro-4a,12-diaza-cycloocta[b]naphthalen-5-one
|
|
3 | 228.29 |
| 17-174-0 |
4-Quinolinol, 4-ethenyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«alpha»,8a«beta»)-
|
20431-93-0 |
3 | 209.33 |
| 17-211-8 |
Spirocyclopentane-2-(1,5,6-triazabicyclo[3.1.0]hexane), 4,4,6-tris(trifluoromethyl)-
|
|
3 | 343.19 |
| 17-274-9 |
6H-Pyrazolo[1,2-a][1,2,4,5]tetrazine, hexahydro-2,3-dimethyl-
|
70517-50-9 |
3 | 156.23 |
| 17-301-8 |
2,6-Pyridinedicarboxylic acid, 2-methylhex-3-yl 2,4,4-trimethylpentyl ester
|
|
3 | 377.52 |
| 17-642-0 |
1-(2-Methylbutoxy)-7-pentyl-2,2,4,4,6,6-hexamethyl-1,3,5,7-tetraoxa-2,4,6-trisilaheptane
|
|
3 | 380.74 |
| 17-661-9 |
N-(4-Methoxy-1,3-benzothiazol-2-yl)-N-(2,2,3,3,3-pentafluoropropanoyl)-2,2,3,3,3-pentafluoropropanamide
|
|
3 | 472.26 |
| 17-969-8 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, tetradecyl ester
|
|
3 | 565.64 |
| 18-152-3 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 3-methyl
|
|
3 | 160.18 |
| 18-213-5 |
2-O-acetyl-8,12-epoxygermacra-1(10),4,7,11-tetraene, isomer I
|
|
3 | 274.35 |
| 18-430-4 |
5-Quinolinesulfonic acid, 8-hydroxy-7-(6-sulfo-2-naphthylazo)-
|
56990-57-9 |
3 | 459.45 |
| 18-481-8 |
Benzeneacetic acid, «alpha»-hydroxy-«alpha»-phenyl-, 1-methyl-3-piperidinyl ester
|
3321-80-0 |
3 | 325.40 |
| 18-495-3 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, butyl ester
|
|
3 | 339.38 |
| 18-921-9 |
7,8,9,10-Tetrahydro-6H-cyclohepta[d]pyrido[1,2-a]pyrimidin-11-one
|
|
3 | 234.34 |
| 18-998-5 |
3H-Pyrazol-3-one, 2,4-dihydro-2,5-dimethyl-
|
2749-59-9 |
3 | 112.13 |
| 19-052-3 |
(9Z,11E)-Hexadeca-9,11-dien-1-ol, adduct with 4-methyl-3,5-dihydro-1,2,4-triazole-3,5-dione
|
|
3 | 351.48 |
| 19-101-8 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, butyl ester
|
|
3 | 425.37 |
| 19-223-3 |
3-Ethyl-2-isopropyl-3,5-dimethyl-1,4,2-diazaphosphorine-2-oxide
|
|
3 | 266.32 |
| 19-257-6 |
O-Ethyl-O-(1,1-difluoro-2-bromoethyl)-N-propyl-phosphorothioamidate
|
|
3 | 326.14 |
| 19-309-8 |
Spirocyclohexane-2-(1,5,6-triazabicyclo[3.1.0]hexane), 4,4,6-tris(trifluoromethyl)-
|
130720-67-1 |
3 | 357.22 |
| 19-472-7 |
1,3-Cyclobutanediimine, n,n'-dicyclohexyl-2,2,4,4-tetramethyl
|
|
3 | 302.51 |
| 19-532-0 |
N,n-dimethyl-p-methyl phosphonamidic acid, n-propyl ester
|
|
3 | 165.17 |
| 19-562-7 |
1,3,5(10)-Oestratriene-2,3,17.beta.-triol, 2,3-TMS-17-HFB
|
|
3 | 628.77 |
| 19-648-2 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, isohexyl ester
|
|
3 | 367.43 |
| 19-666-2 |
cis-N-(1-Bicyclo[2.2.1]heptyl)-N'-(1-bicyclo[2.2.2]octyl)diazene
|
|
3 | 232.37 |
| 19-671-6 |
1,3,5(10)-Oestratriene-2-methoxy-3,17«beta»-diol, 3-TBDMS-17-HFB
|
|
3 | 612.69 |
| 19-705-8 |
allo-Cholanic acid, 3«beta»,7«beta»,12«beta»-trihydroxy, Me-DMES
|
|
3 | 681.22 |
| 19-865-1 |
Naphtho[1,8',8:c,d]cyclodeca-1,5-diiyne
|
|
3 | 216.28 |
| 20-180-9 |
1,3-Disiloxane, 1,3-dimethyl, 1,3-bis-(chloromethyl), 1,3-bis-ethenyl
|
|
3 | 255.29 |
| 20-217-8 |
Di[1,1'-biphenyl]-2-yl 4-(1-phenylethyl)phenyl phosphate
|
116402-02-9 |
3 | 582.62 |
| 20-274-5 |
[(1R)-7-(Hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-1-yl] hexanoate
|
|
3 | 267.36 |
| 20-406-8 |
N-(2-Hydroxy-propionyl)-4-methyl-benzenesulfonamide, N,O-di(trimethylsilyl)-
|
|
3 | 387.65 |
| 20-445-5 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, pentyl ester
|
|
3 | 387.40 |
| 20-740-7 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5-dimethyl-7,7-tetramethylene
|
|
3 | 222.29 |
| 20-826-2 |
24-Nor-5«beta»-cholane-3«alpha»,7«alpha»,23-triol, TMS
|
|
3 | 581.11 |
| 20-849-7 |
Irgacure 369 (2-Benzyl-2-(dimethylamino)-1-[4-(morpholinyl) phenyl)]-1-butanone)
|
|
3 | 366.50 |
| 21-019-7 |
Thiazolo[3,2-a]pyridinium, 3-hydroxy-2-phenyl-, hydroxide, inner salt
|
|
3 | 227.29 |
| 21-039-5 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, isohexyl ester
|
|
3 | 401.42 |
| 21-246-5 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,5,6-trimethyl
|
|
3 | 182.22 |
| 21-300-4 |
Phosphoric acid, 2-(diethylamino)-6-methyl-4-pyrimidinyl diethyl ester
|
|
3 | 317.33 |
| 21-497-7 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-allyl-phosphorothioamidate
|
|
3 | 279.67 |
| 21-616-4 |
Pyridine, 1,1'-[1,2-phenylenebis(1-oxo-2,1-ethanediyl)]bis[1,2,3,4-tetrahydro-
|
|
3 | 324.42 |
| 21-695-7 |
allo-Cholanic acid, 3«alpha»,7«beta»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 639.14 |
| 21-745-1 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, butyl ester
|
|
3 | 373.37 |
| 22-124-9 |
1,1'-Bis[n-methyl-n-(4-nitrophenyl)-carboxamido] ferrocene
|
|
3 | 542.32 |
| 22-150-0 |
5,5-Dimethyl-2-phenyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 218.25 |
| 22-200-4 |
7,14-Methano-4H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine-4,13(14H)-dione, decahydro-, [7S-(7«alpha»,7a«beta»,14«alpha»,14a«alpha»)]-
|
|
3 | 262.35 |
| 22-377-9 |
6H-Pyrido[2,1-b]quinazolin-6-one, 7,8,9,10-tetrahydro-6-methyl
|
|
3 | 214.26 |
| 22-392-2 |
Cyclopentyl-hydroxy-phenyl-acetic acid 1-methyl-pyrrolidin-3-yl ester
|
|
3 | 303.40 |
| 22-415-6 |
Thiazolo[3,2-a]pyridinium, 8-hydroxy-3-methyl-, hydroxide, inner salt
|
30276-99-4 |
3 | 165.21 |
| 22-588-5 |
5-Methyl-2H-pyrazole-3-carboxylic acid, 2,2-tetramethylene hydrazide
|
|
3 | 194.23 |
| 22-957-5 |
4H-cyclopenteno[2,3-e]pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro
|
|
3 | 186.21 |
| 23-018-6 |
Thiazolo[3,2-a]pyridinium, 2,3-dihydro-8-hydroxy-5-methyl-, hydroxide, inner salt
|
23003-43-2 |
3 | 167.23 |
| 23-150-9 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-17«beta»-ol, monoTMS
|
|
3 | 360.65 |
| 23-171-6 |
2,5,5-Trimethyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 156.18 |
| 23-277-9 |
4-Quinolinol,1-ethyl-4-ethynyldecahydro-2-methyl-(2«alpha»,4«beta»,4a«alpha»,8a«beta»)
|
38463-55-7 |
3 | 221.34 |
| 23-932-1 |
2,6-Pyridinedicarboxylic acid, 1-methoxydec-4-yl propyl ester
|
|
3 | 379.49 |
|
« Previous Results
Next Results »
|